TCW Group Inc. Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

TCW Group Inc. decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 260,309 shares of the healthcare conglomerate’s stock after selling 8,916 shares during the quarter. UnitedHealth Group comprises 1.1% of TCW Group Inc.’s holdings, making the stock its 24th largest position. TCW Group Inc.’s holdings in UnitedHealth Group were worth $131,680,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. FPC Investment Advisory Inc. increased its stake in UnitedHealth Group by 863.6% during the fourth quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock worth $58,000 after acquiring an additional 95 shares during the last quarter. Fisher Funds Management LTD acquired a new stake in UnitedHealth Group during the fourth quarter worth $139,850,000. First Horizon Advisors Inc. increased its stake in UnitedHealth Group by 3.0% during the fourth quarter. First Horizon Advisors Inc. now owns 6,652 shares of the healthcare conglomerate’s stock worth $3,365,000 after acquiring an additional 194 shares during the last quarter. Capital City Trust Co. FL increased its stake in UnitedHealth Group by 4.6% during the fourth quarter. Capital City Trust Co. FL now owns 8,067 shares of the healthcare conglomerate’s stock worth $4,081,000 after acquiring an additional 355 shares during the last quarter. Finally, 44 Wealth Management LLC increased its stake in UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after acquiring an additional 21 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 7.3 %

UnitedHealth Group stock opened at $465.58 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61. The stock has a 50-day simple moving average of $519.27 and a 200-day simple moving average of $560.48.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the business earned $5.83 EPS. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Insider Activity

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on UNH shares. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft lifted their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Finally, KeyCorp reaffirmed an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.